financetom
Business
financetom
/
Business
/
Dominion Lending Centres Inquiry Shelved by Competition Bureau
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dominion Lending Centres Inquiry Shelved by Competition Bureau
Jun 21, 2024 3:41 AM

06:26 AM EDT, 06/21/2024 (MT Newswires) -- Dominion Lending Centres (DLGC.TO) on Thursday said the Competition Bureau had shelved an inquiry into the company's conduct.

In May 2023, a court order forced Dominion to turn over documents, records and data in connection with the inquiry, which related to allegations of anti-competitive conduct by the company.

"We are dedicated to regulatory compliance in all aspects of our business and are pleased the inquiry has been discontinued," said Gary Maris, chairman and CEO of Dominion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mln
Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mln
Nov 12, 2025
Overview * BeyondSpring ( BYSI ) Q3 net loss narrows to $1.7 mln from $2.2 mln last year * Plinabulin shows promising results in NSCLC patients at SITC 2025 presentations * SEED secures $30 mln financing, achieves IND clearance for RBM39 program Outlook * BeyondSpring ( BYSI ) emphasizes Plinabulin's potential in resensitizing tumors resistant to checkpoint inhibitors * Company...
Radcom beats Q3 revenue estimates on AI and 5G adoption
Radcom beats Q3 revenue estimates on AI and 5G adoption
Nov 12, 2025
Overview * Radcom ( RDCM ) Q3 revenue grows 16% yr/yr, beating analyst expectations * Company achieves highest operating margin in seven years, driven by AI and 5G adoption * Radcom ( RDCM ) reaffirms full-year 2025 guidance of 15%-18% revenue growth Outlook * Radcom ( RDCM ) reaffirms full-year 2025 revenue growth guidance of 15%-18% * Company maintains strong...
Pharvaris Q3 Loss Narrows
Pharvaris Q3 Loss Narrows
Nov 12, 2025
07:08 AM EST, 11/12/2025 (MT Newswires) -- Pharvaris ( PHVS ) late Wednesday reported a Q3 net loss of 0.60 euros ($0.69) per diluted share, narrower than a loss of 0.77 euro a year earlier. Analysts polled by FactSet expected a 0.67 euros per share loss. As of Sept. 30, the company said its cash and cash equivalents were 329...
Biopharma firm Acumen's Q3 net loss narrows, beats estimates
Biopharma firm Acumen's Q3 net loss narrows, beats estimates
Nov 12, 2025
Overview * Acumen Q3 net income and income from operations beat analyst estimates * Company's cash expected to support operations into early 2027 * R&D expenses decreased due to reduced CRO costs for ALTITUDE-AD trial Outlook * Company expects topline results from ALTITUDE-AD study in late 2026 * Company anticipates non-clinical data to inform EBD strategy in early 2026 *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved